Fewer Can Be Better: Single-Vendor Purchasing of Spinal Implants Brings Savings While Preserving Outcomes
Single-center retrospective analysis defies conventional wisdom
Related Articles
Gut Microbial TMAO Pathway Associated With Incident Heart Failure
What do dietary substrates, gut microbe metabolites and heart failure have in common? Our latest research reveals a fascinating link. Our researchers have identified a…
Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects?
A team of Cleveland Clinic researchers is exploring new antidotes against fentanyl overdose that eliminate the respiratory depression effects of opioids without interfering with their…
Digging Deeper into Racial and Socioeconomic Disparities in Pediatric Heart Transplant
Numerous studies have identified that Black children have worse waitlist and post-transplant outcomes, but very few have examined why these disparities exist. Shahnawaz Amdani, MD,…
Multidisciplinary Rehab Team Helps Patient Make Full Recovery From Severe Ski Accident
How neurorehabilitation at Cleveland Clinic London Hospital enabled a 34-year-old to fully recover from traumatic brain injury following devastating ski accident
Case Study: Patient with Metastatic Urothelial Carcinoma Has No Remaining Evidence of Disease
A patient with metastatic urothelial carcinoma has no evidence of disease after receiving a checkpoint inhibitor, surgery and intravesical therapy.
Testing Cancer Drugs in Patients With Lymphatic Malformation
Cleveland Clinic Children’s will begin two clinical trials studying the use of common cancer drugs in the treatment of patients with lymphatic malformations.
CAR T-Cell Treatment Offers Hope for Richter Transformation
Research found a one-time infusion of lisocabtagene maraleucel (“liso-cel”) led to a high one-year survival rate of 67% with a manageable safety profile in patients…
Immunotherapy Service Provides Care and Trial Opportunities
Cleveland Clinic has developed a new inpatient Cellular and Immunotherapy Service, with teams specially trained in emerging cancer therapies.
Lipoprotein(a): Progress on One of the Last Untreatable Frontiers of Cardiovascular Risk
Promising new therapies for this important risk factor are far along in clinical testing. Wider measurement of Lp(a) levels is needed now.
Dr. Elaine Wyllie Shares Insights From a Singular Career in Epilepsy Medicine
As she retires from practice, the pioneering clinician, researcher and educator looks back on nearly four decades of advancements and offers advice for today’s young…